The forecast for malignant neoplasms in the colon, rectum, and anus among females in the US demonstrates a gradually decreasing trend. The mortality rate is expected to decline from 24.15 thousand in 2024 to 23.7 thousand by 2028. This indicates a year-on-year decline of approximately 0.5% annually from 2024 to 2028. Such trends highlight improvements in healthcare interventions, early detection, and treatment effectiveness, considering the value stood at 24.15 thousand in 2023.

Future trends to watch for include:

Advancements in medical technology and personalized medicine which may further decrease mortality rates.
The impact of lifestyle changes and preventative screenings on long-term mortality trends.
Potential disparities in healthcare access that could influence regional variations in mortality rates.